Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Tear-jerker: Brain tumor patient's “final wish” is to find her husband a new ...
Tue, 22 Apr 2014 09:39:12 GMT (ROCKETNEWS24)
Marine father, toddler son both diagnosed with brain tumors
Mon, 21 Apr 2014 20:48:56 GMT (WCTI12.com)
Brain tumor risk higher for teens who stop growing later
Tue, 15 Apr 2014 14:00:41 GMT (Fox News)
Community rallies around UP teen with brain tumor
Sat, 19 Apr 2014 20:11:27 GMT (The Grand Rapids Press)
Army Couple Respond to Brain Cancer Diagnosis
Mon, 21 Apr 2014 15:06:54 GMT (Military.com)
Dallas family honored by children's brain tumor foundation
Tue, 22 Apr 2014 22:05:03 GMT (NeighborNewspapers.com)
Weekend Review: Community rallies around U.P. teen with brain tumor
Mon, 21 Apr 2014 12:19:43 GMT (The Grand Rapids Press)
Bates helps families cope with their child's brain cancer
Tue, 22 Apr 2014 21:01:16 GMT (NeighborNewspapers.com)
VOICES AGAINST BRAIN CANCER TO HOST 2ND ANNUAL "JOIN THE ...
Tue, 22 Apr 2014 15:02:38 GMT (PR Newswire (press release))
Former reporter moves forward despite epilepsy, brain tumor
Sat, 19 Apr 2014 20:10:12 GMT (ABC7Chicago.com)

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
14th Annual UCLA Brain Tumor Conference
May 9th-10th 2014


Join brain cancer survivors, family members, friends and health care professionals at the 2014 UCLA Brain Tumor Conference, hosted by the UCLA Neuro-Oncology Program.

This FREE conference will offer participants the opportunity to hear leading healthcare professionals speak about the latest treatments for brain tumors. Through this conference, the Neuro-Oncology Program promotes the sharing of information and experience between brain tumor survivors, their families, friends and health care professionals.

• PARKING INFORMATION!
• Conference Schedule  • Registration: Sign Up

Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2014 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2014 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:4/23/2014 5:50:17 AM PST]